keyword
MENU ▼
Read by QxMD icon Read
search

Frank detterbeck

keyword
https://www.readbyqxmd.com/read/28183483/achieving-clarity-about-lung-cancer-and-opacities
#1
EDITORIAL
Frank C Detterbeck
No abstract text is available yet for this article.
February 2017: Chest
https://www.readbyqxmd.com/read/28056112/association-of-delayed-adjuvant-chemotherapy-with-survival-after-lung-cancer-surgery
#2
Michelle C Salazar, Joshua E Rosen, Zuoheng Wang, Brian N Arnold, Daniel C Thomas, Roy S Herbst, Anthony W Kim, Frank C Detterbeck, Justin D Blasberg, Daniel J Boffa
Importance: Adjuvant chemotherapy offers a survival benefit to a number of staging scenarios in non-small-cell lung cancer. Variable recovery from lung cancer surgery may delay a patient's ability to tolerate adjuvant chemotherapy, yet the urgency of chemotherapy initiation is unclear. Objective: To assess differences in survival according to the time interval between non-small-cell lung cancer resection and the initiation of postoperative chemotherapy to determine the association between adjuvant treatment timing and efficacy...
January 5, 2017: JAMA Oncology
https://www.readbyqxmd.com/read/28043473/estimating-the-annual-incremental-cost-of-several-complications-following-pulmonary-lobectomy
#3
Oliver K Jawitz, Daniel J Boffa, Frank C Detterbeck, Zuoheng Wang, Anthony W Kim
Determine the incremental increase in cost as well as length of hospital stay associated with several major complications following pulmonary lobectomy using a large national dataset. A retrospective cohort analysis of the 2012 National Inpatient Sample, Healthcare Cost and Utilization Project database was performed. Demographic and clinical data on patients ≥18 years having undergone an open or VATS lobectomy were included in the analysis. The median increase in cost and length of stay associated with relevant major complications were determined using a multivariable quantile regression model...
July 2016: Seminars in Thoracic and Cardiovascular Surgery
https://www.readbyqxmd.com/read/28024700/defining-outcomes-of-patients-with-clinical-stage-i-small-cell-lung-cancer-upstaged-at-surgery
#4
Daniel C Thomas, Brian N Arnold, Joshua E Rosen, Michelle C Salazar, Justin D Blasberg, Frank C Detterbeck, Daniel J Boffa, Anthony W Kim
BACKGROUND: A proportion of patients with clinical stage I small cell lung cancer (SCLC) will be upstaged following surgical resection. The existing data regarding the management of upstaged SCLC patients and guidelines for their treatment remains sparse. The primary objective was to describe the impact of pathologic upstaging following surgical resection. METHODS: The National Cancer Database was queried for patients with clinical stage I SCLC (cT1-2a,N0,M0) who underwent resection with curative intent followed by adjuvant therapy, excluding patients who underwent surgery alone...
January 2017: Lung Cancer: Journal of the International Association for the Study of Lung Cancer
https://www.readbyqxmd.com/read/27890561/role-of-adjuvant-therapy-for-node-negative-lung-cancer-invading-the-chest-wall
#5
Sarah J Gao, Christopher D Corso, Justin D Blasberg, Frank C Detterbeck, Daniel J Boffa, Roy H Decker, Anthony W Kim
INTRODUCTION: The present study investigated the effect of adjuvant chemotherapy and radiation on survival among patients undergoing chest wall resection for T3N0 non-small cell lung cancer (NSCLC). MATERIALS AND METHODS: Patients with T3N0 NSCLC who underwent chest wall resection were identified in the National Cancer Data Base in 2004 to 2012. The cohort was divided into patients who had received adjuvant chemotherapy, radiation therapy, chemoradiation therapy, or no adjuvant treatment...
October 17, 2016: Clinical Lung Cancer
https://www.readbyqxmd.com/read/27876674/thymic-carcinoma-management-patterns-among-international-thymic-malignancy-interest-group-itmig-physicians-with-consensus-from-the-thymic-carcinoma-working-group
#6
Annemarie Shepherd, Gregory Riely, Frank Detterbeck, Charles B Simone, Usman Ahmad, James Huang, Robert Korst, Arun Rajan, Andreas Rimner
INTRODUCTION: Thymic carcinomas are rare epithelial malignancies with limited data to guide management. METHODS: To identify areas of agreement and variability in current clinical practice, a 16-question electronic survey was given to members of the International Thymic Malignancy Interest Group (ITMIG). Areas of controversy were discussed with the Thymic Carcinoma Working Group and consensus was achieved, as described. RESULTS: A total of 100 ITMIG members responded...
November 19, 2016: Journal of Thoracic Oncology
https://www.readbyqxmd.com/read/27780786/the-eighth-edition-lung-cancer-stage-classification
#7
REVIEW
Frank C Detterbeck, Daniel J Boffa, Anthony W Kim, Lynn T Tanoue
Stage classification provides a nomenclature about the anatomic extent of a cancer; a consistent language provides the ability to communicate about a specific patient and about cohorts of patients in clinical studies. This paper summarizes the eighth edition of lung cancer stage classification, which is the worldwide standard as of January 1, 2017. This revision is based on a large global database, a sophisticated analysis, extensive internal validation as well as multiple assessments confirming generalizability...
January 2017: Chest
https://www.readbyqxmd.com/read/27735079/dataset-for-reporting-of-thymic-epithelial-tumours-recommendations-from-the-international-collaboration-on-cancer-reporting-iccr
#8
Andrew G Nicholson, Frank Detterbeck, Alexander Marx, Anja C Roden, Alberto M Marchevsky, Kiyoshi Mukai, Gang Chen, Mirella Marino, Michael A den Bakker, Woo-Ick Yang, Meagan Judge, Lynn Hirschowitz
AIMS: The International Collaboration on Cancer Reporting (ICCR) is a not-for-profit organization formed by the Royal Colleges of Pathologists of Australasia and the United Kingdom, the College of American Pathologists, the Canadian Association of Pathologists-Association Canadienne des Pathologists in association with the Canadian Partnership Against Cancer, and the European Society of Pathology. Its goal is to produce standardized, internationally agreed, evidence-based datasets for use throughout the world...
March 2017: Histopathology
https://www.readbyqxmd.com/read/27720827/timing-of-surgery-after-neoadjuvant-chemoradiation-in-locally-advanced-non-small-cell-lung-cancer
#9
Sarah J Gao, Christopher D Corso, Elyn H Wang, Justin D Blasberg, Frank C Detterbeck, Daniel J Boffa, Roy H Decker, Anthony W Kim
INTRODUCTION: A subset of patients with potentially resectable clinical stage IIIA NSCLC are managed with trimodality therapy. However, little data exist to guide the timing of surgery after neoadjuvant therapy. This study examined whether the time interval between neoadjuvant chemoradiation (NCRT) and surgical resection affects overall survival. METHODS: Patients with clinical stage IIIA disease (T1-3 N2) NSCLC who underwent NCRT were identified in the National Cancer Data Base (NCDB) between 2004 and 2012 and categorized on the basis of the interval between chemoradiation and surgery (0 to ≤3, >3 to ≤6, >6 to ≤9, and >9 to ≤12 weeks)...
February 2017: Journal of Thoracic Oncology
https://www.readbyqxmd.com/read/27687847/hospital-volume-and-outcomes-of-robot-assisted-lobectomies
#10
Lise N Tchouta, Henry S Park, Daniel J Boffa, Justin D Blasberg, Frank C Detterbeck, Anthony W Kim
BACKGROUND: The positive impact of hospital operative volume on outcomes following video-assisted thoracoscopic surgery has been established. The goal of this study was to determine whether or not this volume-outcome relationship translates to robotic-assisted thoracoscopic surgery (RobATS) lobectomy. METHODS: Patients who underwent RobATS lobectomy were identified between 2008 and 2013 in the Healthcare Cost and Utilization Project National Inpatient Sample (HCUP-NIS) database...
September 26, 2016: Chest
https://www.readbyqxmd.com/read/27619638/the-impact-of-chart-on-the-science-of-thymic-malignancies
#11
EDITORIAL
Frank Detterbeck
No abstract text is available yet for this article.
August 2016: Journal of Thoracic Disease
https://www.readbyqxmd.com/read/27565401/selective-application-of-lobe-specific-node-dissection
#12
EDITORIAL
Frank C Detterbeck
No abstract text is available yet for this article.
September 2016: Journal of Thoracic Oncology
https://www.readbyqxmd.com/read/27564681/length-of-stay-from-the-hospital-perspective-practice-of-early-discharge-is-not-associated-with-increased-readmission-risk-after-lung-cancer-surgery
#13
Joshua E Rosen, Michelle C Salazar, Kumar Dharmarajan, Anthony W Kim, Frank C Detterbeck, Daniel J Boffa
OBJECTIVE: To determine if hospitals that routinely discharge patients early after lobectomy have increased readmissions. BACKGROUND: Hospitals are increasingly motivated to reduce length of stay (LOS) after lung cancer surgery, yet it is unclear if a routine of early discharge is associated with increased readmissions. The relationship between hospital discharge practices and readmission rates is therefore of tremendous clinical and financial importance. METHODS: The National Cancer Database was queried for patients undergoing lobectomy for lung cancer from 2004 to 2013 at Commission on Cancer-accredited hospitals, which performed at least 25 lobectomies in a 2-year period...
August 25, 2016: Annals of Surgery
https://www.readbyqxmd.com/read/27458143/the-differential-impact-of-preoperative-comorbidity-on-perioperative-outcomes-following-thoracoscopic-and-open-lobectomies
#14
Oliver K Jawitz, Zuoheng Wang, Daniel J Boffa, Frank C Detterbeck, Justin D Blasberg, Anthony W Kim
OBJECTIVES: Video-assisted thoracoscopic surgery (VATS) lobectomy is quickly becoming the standard of care for many patients with early-stage non-small-cell lung cancer (NSCLC) and benign lung conditions. There is a lack of published data defining the differential impact of preoperative patient comorbidity on outcomes following VATS and OPEN lobectomies, which would be beneficial for procedure selection and clinical decision-making. METHODS: A retrospective analysis of the 2008-2011 Nationwide Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP) database was performed...
January 2017: European Journal of Cardio-thoracic Surgery
https://www.readbyqxmd.com/read/27448762/the-iaslc-lung-cancer-staging-project-methodology-and-validation-used-in-the-development-of-proposals-for-revision-of-the-stage-classification-of-nsclc-in-the-forthcoming-eighth-edition-of-the-tnm-classification-of-lung-cancer
#15
Frank C Detterbeck, Kari Chansky, Patti Groome, Vanessa Bolejack, John Crowley, Lynn Shemanski, Catherine Kennedy, Mark Krasnik, Michael Peake, Ramón Rami-Porta
INTRODUCTION: Stage classification provides a consistent language to describe the anatomic extent of disease and is therefore a critical tool in caring for patients. The Staging and Prognostic Factors Committee of the International Association for the Study of Lung Cancer developed proposals for revision of the classification of lung cancer for the eighth edition of the tumor, node, and metastasis (TNM) classification, which takes effect in 2017. METHODS: An international database of 94,708 patients with lung cancer diagnosed in 1999-2010 was assembled...
September 2016: Journal of Thoracic Oncology
https://www.readbyqxmd.com/read/27346413/postoperative-radiation-therapy-is-associated-with-longer-overall-survival-in-completely-resected-stage-ii-and-iii-thymoma-an-analysis-of-the-international-thymic-malignancies-interest-group-retrospective-database
#16
Andreas Rimner, Xiaopan Yao, James Huang, Alberto Antonicelli, Usman Ahmad, Robert J Korst, Frank Detterbeck, Daniel R Gomez
OBJECTIVES: The aim of this study was to determine whether postoperative radiation therapy (PORT) is associated with an overall survival (OS) benefit in patients with completely resected Masaoka or Masaoka-Koga stage II and III thymoma. METHODS: All patients with completely resected (R0) stage II or III thymoma were identified in a large database of the International Thymic Malignancy Interest Group. Clinical, pathologic, treatment, and follow-up information were extracted...
October 2016: Journal of Thoracic Oncology
https://www.readbyqxmd.com/read/27131846/lobectomy-versus-stereotactic-body-radiotherapy-in-healthy-patients-with-stage-i-lung-cancer
#17
COMPARATIVE STUDY
Joshua E Rosen, Michelle C Salazar, Zuoheng Wang, James B Yu, Roy H Decker, Anthony W Kim, Frank C Detterbeck, Daniel J Boffa
OBJECTIVES: Stereotactic body radiotherapy is an effective treatment for patients with early-stage non-small cell lung cancer who are not healthy enough to undergo surgery; however, the relative efficacy versus surgery in healthy patients is unknown. The National Cancer Database contains information on patient health and eligibility for surgery, allowing the long-term survival associated with lobectomy and stereotactic body radiotherapy to be compared in healthy patients with clinical stage I disease...
July 2016: Journal of Thoracic and Cardiovascular Surgery
https://www.readbyqxmd.com/read/27118714/analyzing-risk-factors-for-morbidity-and-mortality-after-lung-resection-for-lung-cancer-using-the-nsqip-database
#18
Raymond A Jean, Matthew R DeLuzio, Alexander I Kraev, Gongyi Wang, Daniel J Boffa, Frank C Detterbeck, Zuoheng Wang, Anthony W Kim
BACKGROUND: Our goal was to develop a predictive model that identifies how preoperative risk factors and perioperative complications lead to mortality after anatomic pulmonary resections. STUDY DESIGN: This was a retrospective cohort study. The American College of Surgeons NSQIP database was examined for all patients undergoing elective lobectomies for cancer from 2005 through 2012. Fifty-eight pre- and intraoperative risk factors and 13 complications were considered for their impact on perioperative mortality within 30 days of surgery...
June 2016: Journal of the American College of Surgeons
https://www.readbyqxmd.com/read/27107787/the-iaslc-lung-cancer-staging-project-proposals-for-coding-t-categories-for-subsolid-nodules-and-assessment-of-tumor-size-in-part-solid-tumors-in-the-forthcoming-eighth-edition-of-the-tnm-classification-of-lung-cancer
#19
REVIEW
William D Travis, Hisao Asamura, Alexander A Bankier, Mary Beth Beasley, Frank Detterbeck, Douglas B Flieder, Jin Mo Goo, Heber MacMahon, David Naidich, Andrew G Nicholson, Charles A Powell, Mathias Prokop, Ramón Rami-Porta, Valerie Rusch, Paul van Schil, Yasushi Yatabe
This article proposes codes for the primary tumor categories of adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA) and a uniform way to measure tumor size in part-solid tumors for the eighth edition of the tumor, node, and metastasis classification of lung cancer. In 2011, new entities of AIS, MIA, and lepidic predominant adenocarcinoma were defined, and they were later incorporated into the 2015 World Health Organization classification of lung cancer. To fit these entities into the T component of the staging system, the Tis category is proposed for AIS, with Tis (AIS) specified if it is to be distinguished from squamous cell carcinoma in situ (SCIS), which is to be designated Tis (SCIS)...
August 2016: Journal of Thoracic Oncology
https://www.readbyqxmd.com/read/27103511/lung-cancer-in-the-very-young-treatment-and-survival-in-the-national-cancer-data-base
#20
Brian N Arnold, Daniel C Thomas, Joshua E Rosen, Michelle C Salazar, Justin D Blasberg, Daniel J Boffa, Frank C Detterbeck, Anthony W Kim
INTRODUCTION: Young patients with lung cancer represent a distinct subset of patients with this disease. The National Cancer Data Base includes patients of all ages and contains detailed staging, treatment, and survival information. The objective of this study was to examine treatment patterns and outcomes in young patients with non-small cell lung cancer (NSCLC). METHODS: The National Cancer Data Base was queried for NSCLC cases from 2003 to 2009. Younger patients were defined as those aged 20 to 46 years...
July 2016: Journal of Thoracic Oncology
keyword
keyword
83633
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"